FUKOKU MUTUAL LIFE INSURANCE Co Invests $234,000 in DocuSign, Inc. (NASDAQ:DOCU)

FUKOKU MUTUAL LIFE INSURANCE Co bought a new stake in DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,604 shares of the company’s stock, valued at approximately $234,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. State Street Corp increased its stake in DocuSign by 2.3% in the third quarter. State Street Corp now owns 5,372,939 shares of the company’s stock valued at $333,604,000 after acquiring an additional 120,743 shares during the period. Geode Capital Management LLC boosted its position in DocuSign by 1.6% in the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock valued at $215,789,000 after buying an additional 53,554 shares in the last quarter. Thrivent Financial for Lutherans boosted its position in DocuSign by 5.2% in the third quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company’s stock valued at $141,398,000 after buying an additional 112,919 shares in the last quarter. FMR LLC boosted its position in DocuSign by 16.8% in the third quarter. FMR LLC now owns 2,192,885 shares of the company’s stock valued at $136,156,000 after buying an additional 315,073 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of DocuSign by 61.5% during the fourth quarter. Bank of New York Mellon Corp now owns 1,673,612 shares of the company’s stock worth $150,525,000 after purchasing an additional 637,505 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.

DocuSign Stock Up 0.8 %

Shares of NASDAQ:DOCU opened at $82.28 on Thursday. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The company’s fifty day simple moving average is $90.91 and its 200 day simple moving average is $77.33. The firm has a market cap of $16.62 billion, a price-to-earnings ratio of 16.96, a PEG ratio of 6.94 and a beta of 0.89.

Insider Buying and Selling

In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction on Monday, December 16th. The shares were sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the sale, the director now owns 7,736 shares in the company, valued at $731,825.60. The trade was a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 693,773 shares of company stock worth $66,727,926 over the last ninety days. Company insiders own 1.66% of the company’s stock.

Analysts Set New Price Targets

DOCU has been the topic of several research analyst reports. HSBC reissued a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Robert W. Baird raised their price objective on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Morgan Stanley raised their price objective on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Finally, Citigroup raised their price objective on shares of DocuSign from $87.00 to $113.00 and gave the company a “buy” rating in a research note on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, DocuSign currently has an average rating of “Hold” and an average price target of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.